Vimarsana
Biggest News Aggregation in the World

Linux Based Tizen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linux Based Tizen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linux Based Tizen Today - Breaking & Trending Today

Samsung Joins Korean Rival LG in Licensing Smart TV OS to Third-Party Manufacturers - Vimarsana News

Samsung Joins Korean Rival LG in Licensing Smart TV OS to Third-Party Manufacturers

Samsung Tizen TVOS will now be used by Akai, RCA and other smart TV brands sold in Europe, Australia and New Zealand

Source: nexttv.com
Fire TV, Roku, WebOS, and More: A Guide to Smart TV Platforms - Vimarsana News

Fire TV, Roku, WebOS, and More: A Guide to Smart TV Platforms

Amazon, Google, LG, Roku, Samsung, and Vizio all offer ways to access apps, streaming services, and more on your TV. Here's what you need to know about the most popular smart TV platforms.

Source: pcmag.com
Samsung Is Developing a Game Streaming Service for Smart TVs - Vimarsana News

Samsung Is Developing a Game Streaming Service for Smart TVs

The 'Cloud Game Platform' will be for Samsung TVs running the Tizen OS.

Source: pcmag.com
Samsung announces cloud gaming service for its smart TVs - Vimarsana News

Samsung announces cloud gaming service for its smart TVs

Samsung made the announcement at its Developer Conference keynote. The company didn't spend very much time talking about the service, though Yongjae Kim, Samsung's Senior Vice President...

Galaxy Watch 4 features: Samsung plans Google Wear OS adoption sans blood sugar tracking, report says - Vimarsana News

Galaxy Watch 4 features: Samsung plans Google Wear OS adoption sans blood sugar tracking, report says

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.